
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79464 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-N-methyladenosine
CAS:Formula:C32H33N5O5Molecular weight:567.65(4S,4aS,5aR,12aS)-4-(Dimethylamino)-7-fluoro-3,10,12,12a-tetrahydroxy-1,11-dioxo-9-((S)-2-(pyrrolidin-1-yl)propanamido)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
CAS:Formula:C28H33FN4O8Molecular weight:572.59(14S,18S)-1-(6-Hydrazineylidene-1,6-dihydropyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid
CAS:Formula:C24H37N7O9Molecular weight:567.62,2\'-((((4,8-di(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(oxy))bis(ethane-2,1-diyl))bis(azanediyl))bis(ethan-1-ol)
CAS:Formula:C24H40N8O4Molecular weight:504.64Isopropyl 5-hydroxy-2-methyl-4-(3-nitrophenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate
CAS:Formula:C16H18N2O6Molecular weight:334.33(2S)-2-(2-Hydroxy-5-oxo-3-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide
CAS:Formula:C11H18N2O3Molecular weight:226.28Benzyl (2S,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS:Formula:C15H18N2O3SMolecular weight:306.38Amoxicillin Trihydrate mixture with Potassium Clavulanate (4:1)
Formula:(C16H19N3O5S)C8H8NO4SK(H2O)Molecular weight:4(365.40) : 214.22 : 39.10 : 3(18.02)(4S,5R)-5-((R,E)-Hex-4-en-2-yl)-3-methyl-2-oxo-N-((4S,7S,10R,13S,16S,19S,22S,28S)-4,7,16,22-tetraisobutyl-19-isopropyl-8,10,13,17,23,26-hexamethyl-3,6,9,12,15,18,21,24,27-nonaoxo-2,5,8,11,14,17,20,23,26-nonaazatriacontan-28-yl)oxazolidine-4-carboxamide
CAS:Formula:C57H101N11O12Molecular weight:1132.5(2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-((1-(dimethylamino)ethylidene)amino)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
CAS:Formula:C44H55N8O6PMolecular weight:822.95(E)-2-bromo-6-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine
CAS:Formula:C19H21BrN2Molecular weight:357.3(Z)-2-((8S,10S,13S,14S)-10,13-Dimethyl-3-oxo-7,8,12,13,15,16-hexahydro-3H-cyclopenta[a]phenanthren-17(6H,10H,14H)-ylidene)-2-hydroxyacetaldehyde
CAS:Formula:C21H24O3Molecular weight:324.41tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1-nitroso-1H-indole-3-carboxylate
Formula:C25H26IN3O3Molecular weight:543.41(R)-2-((1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)carbamoyl)benzoic Acid
CAS:Formula:C26H25N5O5Molecular weight:487.51Ethyl N,N-bis(2-chloroethyl)-N′-(3-hydroxypropyl)phosphorodiamidate
CAS:Formula:C9H21Cl2N2O3PMolecular weight:307.153-Bromo-6-fluoro-2-methyl-1-((1-methyl-1H-1,2,4-triazol-3-yl)sulfonyl)-1H-indole
Formula:C12H10BrFN4O2SMolecular weight:373.22-(2-(4-(2-Chloroethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole
CAS:Formula:C16H22ClNOMolecular weight:279.8117-Acetyl-17-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
Formula:C22H32O3Molecular weight:344.49(2S,4S)-2-[(Benzoyloxy)methyl]-1,3-dioxolane-4-carboxylic Acid
CAS:Formula:C12H12O6Molecular weight:252.22Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
CAS:Formula:C18H18BrN5O2Molecular weight:416.282,2-Dibromo-1-(4\'-(2-bromoacetyl)-[1,1\'-biphenyl]-4-yl)ethan-1-one
CAS:Formula:C16H11Br3O2Molecular weight:474.97(E)-3-(1-Ethyl-3-(4-fluorophenyl)-1H-indol-2-yl)acrylaldehyde
CAS:Formula:C19H16FNOMolecular weight:293.34Benzhydryl (6R,7S)-3-(chloromethyl)-7-(4-methylbenzamido)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS:Formula:C29H25ClN2O5Molecular weight:516.98Calcium Levofolinate Pentahydrate - Impurity G (Dihydrate Salt)
CAS:Formula:C19H21N7O6(H2O)Molecular weight:443.42 : 2(18.02)(4S)-2-(Carboxy(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)methyl)-3-(2-ethylhexanoyl)-5,5-dimethylthiazolidine-4-carboxylic Acid
CAS:Formula:C27H34ClN3O7SMolecular weight:580.091-(6-((5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)-4-(2-hydroxyethyl)piperazine 1,4-dioxide
CAS:Formula:C22H26ClN7O4SMolecular weight:520.01S-Phenyl (4R,E)-2-(((benzyloxy)carbonyl)(methyl)amino)-4-methyl-3-oxooct-6-enethioate
CAS:Formula:C24H27NO4SMolecular weight:425.543-((2-(Isopropylamino)ethyl)(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)amino)-5-methoxyphenol
CAS:Formula:C24H28N6O2Molecular weight:432.532-(3-(tert-Butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium iodide
Formula:C28H40NO6NIMolecular weight:486.63 : 126.913,3\'-((4-((5-Carboxy-2-hydroxyphenyl)diazenyl)benzoyl)azanediyl)dipropionic Acid
CAS:Formula:C20H19N3O8Molecular weight:429.39(3S,5R,6R,8S,9S,10R,13S,14S)-5-Chloro-6-hydroxy-10,13-dimethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
CAS:Formula:C21H31ClO4Molecular weight:382.935-Bromo-2\'-deoxyuridine 5\'-triphosphate Sodium Salt
CAS:Formula:C9H14BrN2NaO14P3Molecular weight:570.03(E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl Chloride
CAS:Formula:C6H6ClN3O2SMolecular weight:219.64
